Document is current
Any future updates will be listed below
-
Authors
Goligher, Ewan C. https://orcid.org/0000-0002-0990-6701
Combes, Alain
Brodie, Daniel
Ferguson, Niall D.
Pesenti, Antonio M.
Ranieri, V. Marco
Slutsky, Arthur S.
,
Beale, Richard
Brochard, Laurent
Chiche, Jean-Daniel
Fan, Eddy
de Backer, Daniel
Francois, Guy
Laffey, John
Mercat, Alain
McAuley, Daniel F.
Müller, Thomas
Quintel, Michael
Vincent, Jean-Louis
Taccone, Fabio Silvio
Peperstraete, Harlinde
Morimont, Philippe
Schmidt, Matthieu
Levy, Bruno
Diehl, Jean-Luc
Guervilly, Christophe
Capelier, Gilles
Vieillard-Baron, Antoine
Messika, Jonathan
Karagiannidis, Christian
Moerer, Onnen
Urbino, Rosario
Antonelli, Massimo
Mojoli, Francesco
Alessandri, Francesco
Grasselli, Giacomo
Donker, Dirk
Ferrer, Ricard
Mancebo, Jordi
Fanelli, Vito
Pham, Tai
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (AR7-162822)
- License Information
-
More Information
Article History
Received: 9 May 2019
Accepted: 18 July 2019
First Online: 20 August 2019
Compliance with ethical standards
:
: Dr. Goligher reports receiving personal fees and research support in the form of equipment from Getinge. Dr. Brodie is on the medical advisory boards for Baxter, BREETHE, and Hemovent, and past medical advisory board member for ALung Technologies. He currently serves on the Trial Steering Committee for the VENT-AVOID trial sponsored by ALung Technologies. Dr. Ferguson reports receiving personal fees from Getinge, Baxter, and Sedana Medical. Dr. Slutsky reports receiving personal fees from Getinge, Baxter, and Novalung/Xenios.
